CA2328296A1 - Encapsulation devices with strand, yarn or mesh core - Google Patents

Encapsulation devices with strand, yarn or mesh core Download PDF

Info

Publication number
CA2328296A1
CA2328296A1 CA002328296A CA2328296A CA2328296A1 CA 2328296 A1 CA2328296 A1 CA 2328296A1 CA 002328296 A CA002328296 A CA 002328296A CA 2328296 A CA2328296 A CA 2328296A CA 2328296 A1 CA2328296 A1 CA 2328296A1
Authority
CA
Canada
Prior art keywords
yarn
strand
encapsulation devices
mesh core
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002328296A
Other languages
French (fr)
Other versions
CA2328296C (en
Inventor
Rebecca Li
David Rein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurotech USA Inc
Original Assignee
Neurotech S.A.
Rebecca Li
David Rein
Neurotech Usa, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotech S.A., Rebecca Li, David Rein, Neurotech Usa, Inc. filed Critical Neurotech S.A.
Publication of CA2328296A1 publication Critical patent/CA2328296A1/en
Application granted granted Critical
Publication of CA2328296C publication Critical patent/CA2328296C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04C—BRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
    • D04C1/00—Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
    • D04C1/06—Braid or lace serving particular purposes

Abstract

The present invention provides cell encapsulation devices comprising a core of cells or tissue and a strand, yarn or mesh cell-supporting matrix, surrounded by an encapsulating membrane.
CA002328296A 1998-04-13 1999-04-13 Encapsulation devices with strand, yarn or mesh core Expired - Fee Related CA2328296C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8151298P 1998-04-13 1998-04-13
US60/081,512 1998-04-13
US09/289,999 1999-04-12
US09/289,999 US6303136B1 (en) 1998-04-13 1999-04-12 Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
PCT/US1999/008054 WO1999052573A1 (en) 1998-04-13 1999-04-13 Encapsulation devices with strand, yarn or mesh core

Publications (2)

Publication Number Publication Date
CA2328296A1 true CA2328296A1 (en) 1999-10-21
CA2328296C CA2328296C (en) 2008-07-08

Family

ID=26765655

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002328296A Expired - Fee Related CA2328296C (en) 1998-04-13 1999-04-13 Encapsulation devices with strand, yarn or mesh core

Country Status (9)

Country Link
US (2) US6303136B1 (en)
EP (1) EP1083945B1 (en)
AT (1) ATE219691T1 (en)
AU (1) AU748691B2 (en)
CA (1) CA2328296C (en)
DE (1) DE69901957T2 (en)
DK (1) DK1083945T3 (en)
ES (1) ES2178427T3 (en)
WO (1) WO1999052573A1 (en)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152909A1 (en) * 1994-11-16 2003-08-14 Mitrani Eduardo N. In vitro micro-organs, and uses related thereto
WO2003035851A1 (en) * 2001-10-23 2003-05-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
CA2286590C (en) * 1997-04-18 2005-08-02 California Institute Of Technology Multifunctional polymeric tissue coatings
US7687057B2 (en) 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
US6303136B1 (en) * 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US6361771B1 (en) 1999-04-06 2002-03-26 Neurotech S.A. ARPE-19 as a platform cell line for encapsulated cell-based delivery
US20030007954A1 (en) 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
CA2371011C (en) * 1999-04-28 2009-12-22 Eidgenossisch Technische Hochschule Zurich Polyionic coatings in analytic and sensor devices
US6287340B1 (en) * 1999-05-14 2001-09-11 Trustees Of Tufts College Bioengineered anterior cruciate ligament
WO2004006831A2 (en) * 2002-07-12 2004-01-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and device for inducing biological processes by micro-organs
US20030118630A1 (en) * 2001-12-07 2003-06-26 Anthony Cerami Immune modulation device for use in animals
US6958158B2 (en) * 2001-05-11 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc. Immune modulation device for use in animals
US8501396B2 (en) 2001-11-05 2013-08-06 Medgenics Medical Israel Ltd. Dermal micro-organs, methods and apparatuses for producing and using the same
US7468242B2 (en) * 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
EP1451571B1 (en) * 2001-11-05 2013-08-21 Medgenics, Inc. Devices for dosing and administration of therapeutic micro-organs in living subjects
US8088568B2 (en) 2001-11-05 2012-01-03 Medgentics, Inc. Dermal micro-organs, methods and apparatuses for producing and using the same
US6902932B2 (en) * 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
US20110009960A1 (en) * 2001-11-16 2011-01-13 Allergan, Inc. Prosthetic fabric structure
JP2003190259A (en) * 2001-12-28 2003-07-08 Hisako Ogawara Chamber for artificial organ
AU2003234197A1 (en) * 2002-04-22 2003-11-03 Tufts University Multi-dimensional strain bioreactor
US7175624B2 (en) 2002-12-31 2007-02-13 Depuy Spine, Inc. Bone plate and screw system allowing bi-directional assembly
US7914561B2 (en) 2002-12-31 2011-03-29 Depuy Spine, Inc. Resilient bone plate and screw system allowing bi-directional assembly
US7048739B2 (en) * 2002-12-31 2006-05-23 Depuy Spine, Inc. Bone plate and resilient screw system allowing bi-directional assembly
KR100486367B1 (en) * 2003-01-14 2005-04-29 학교법인연세대학교 Biodegradable Dual Porous Scaffold Wrapped with Semi-Permeable Membrane and Tissue Cell Culture Using Thereof
US7341591B2 (en) 2003-01-30 2008-03-11 Depuy Spine, Inc. Anterior buttress staple
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
EP2377403A1 (en) 2003-05-01 2011-10-19 Medgenics, Inc. A genetically modified dermal micro-organ expressing factor VIII
WO2004108760A2 (en) 2003-06-10 2004-12-16 Nsgene A/S Improved secretion of neublastin
US6974862B2 (en) * 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
BRPI0415563A (en) 2003-10-20 2007-01-02 Nsgene As method for treating parkinson's disease, use of a viral vector, viral expression vector, pharmaceutical composition, isolated host cell, packaging cell line, chimeric non-human mammal, implantable cell culture device, biocompatibly capsule, method for treatment of a nervous system disease, mammalian cell, and, method for producing neurturin or a functional equivalent thereof
ATE409741T1 (en) * 2004-01-19 2008-10-15 Nsgene As NERVE GROWTH FACTOR SECRETING HUMAN THERAPEUTIC CELLS
EP2075254A1 (en) 2004-03-30 2009-07-01 NsGene A/S Therapeutic use of a growth factor, NsG33
AU2005279878A1 (en) * 2004-08-30 2006-03-09 Theregen, Inc. Conditioned medium comprising Wnt proteins to promote repair of damaged tissue
US20060046961A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US7754241B1 (en) 2004-11-12 2010-07-13 Clemson University Research Foundation Macromonomer for preparation of a degradable hydrogel
CA2599946A1 (en) * 2005-03-07 2006-09-14 Georgia Tech Research Corporation Nanofilament scaffold for tissue regeneration
US8088567B2 (en) * 2005-04-01 2012-01-03 Nsgene A/S Human immortalised neural precursor cell line
WO2006122550A2 (en) * 2005-05-17 2006-11-23 Nsgene A/S Storage container comprising an implantable therapy system
AU2006308312A1 (en) * 2005-10-28 2007-05-03 Nsgene A/S Implantable Biocompatible Immunoisolatory Vehicle for Delivery of GDNF
AU2006332971B2 (en) * 2005-12-30 2013-03-07 Neurotech Usa, Inc. Micronized device for the delivery of biologically active molecules and methods of use thereof
EP1971293B1 (en) * 2006-01-13 2011-02-23 Barry M. Fell Surgically implantable prosthesis with active component
US20080220042A1 (en) * 2006-01-27 2008-09-11 The Regents Of The University Of California Biomolecule-linked biomimetic scaffolds
JP5249785B2 (en) * 2006-01-27 2013-07-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Biomimetic scaffold
CN101500512B (en) * 2006-02-07 2011-08-24 脊柱赛特有限公司 Methods and compositions for repair of cartilage using an in vivo bioreactor
AU2011253785B2 (en) * 2006-02-07 2013-09-19 Spinalcyte, Llc Methods and compositions for repair of cartilage using an in vivo bioreactor
AU2015202319B2 (en) * 2006-02-07 2017-05-11 Spinalcyte, Llc Method and compositions for repair of cartilage using an in vivo bioreactor.
EP2023852A4 (en) * 2006-06-09 2012-06-27 Univ California Biomolecule-linked biomimetic scaffolds
DE102006042732B3 (en) * 2006-09-12 2008-04-10 Gerlach, Jörg, Dr.med. Artificial capillary membrane system for wound treatment, comprises a capillary hollow fiber membrane system having a common inlet and outlet connected with a pumping device and a fluid media feed pump arranged in the capillary system
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
AU2007294858B2 (en) 2006-09-14 2011-05-12 Medgenics Medical Israel, Ltd Long lasting drug formulations
KR100842067B1 (en) 2007-03-14 2008-06-30 (주)세프라텍 Hollow fiber membrane reinforced with braid
KR100842074B1 (en) 2007-03-14 2008-06-30 (주)세프라텍 Hollow fiber membrane for feeding mixture into inside hollow fiber
WO2008122044A2 (en) * 2007-04-02 2008-10-09 Georgia Tech Research Corporation Implantable device for communicating with biological tissue
AU2008261691A1 (en) * 2007-06-11 2008-12-18 Nanovasc, Inc. Stents
US20100070020A1 (en) 2008-06-11 2010-03-18 Nanovasc, Inc. Implantable Medical Device
US8293531B1 (en) 2007-08-31 2012-10-23 Clemson University Research Foundation Three-dimensional ex vivo system
US9326840B2 (en) 2008-12-15 2016-05-03 Allergan, Inc. Prosthetic device and method of manufacturing the same
US9308070B2 (en) * 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
ES2559228T3 (en) 2008-12-15 2016-02-11 Allergan, Inc. A prosthetic device and a method to manufacture it
US9204954B2 (en) * 2008-12-15 2015-12-08 Allergan, Inc. Knitted scaffold with diagonal yarn
US9204953B2 (en) 2008-12-15 2015-12-08 Allergan, Inc. Biocompatible surgical scaffold with varying stretch
US20100151114A1 (en) * 2008-12-17 2010-06-17 Zimmer, Inc. In-line treatment of yarn prior to creating a fabric
AU2010206374B2 (en) 2009-01-23 2013-01-17 Gloriana Therapeutics Sarl Improved cell lines and their use in encapsulated cell biodelivery
EP2389191A2 (en) 2009-01-23 2011-11-30 NsGene A/S Expression of neuropeptides in mammalian cells
EP2421981B1 (en) * 2009-04-23 2013-08-14 Neurotech USA, Inc. Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
WO2011021712A1 (en) * 2009-08-21 2011-02-24 独立行政法人農業生物資源研究所 Substratum for supplying cells/tissues, cell/tissue supply material and process for production thereof, method for regeneration of tissues, and process for production of porous material
SG178565A1 (en) 2009-08-28 2012-04-27 Sernova Corp Methods and devices for cellular transplantation
NZ598691A (en) * 2009-09-11 2014-05-30 Allergan Inc Prosthetic device and method of manufacturing the same
JP2013506681A (en) 2009-10-02 2013-02-28 バクスター・インターナショナル・インコーポレイテッド Hematopoietic stem cells for use in the treatment of kidney injury
EP2486128A4 (en) * 2009-10-08 2013-10-09 Neurotech Usa Inc Use of pedf in an encapsulated cell-based delivery system
US20110104154A1 (en) * 2009-10-30 2011-05-05 Alcon Research, Ltd. Single nucleotide polymorphisms and genes associated with age-related macular degeneration
JP2013532152A (en) 2010-06-15 2013-08-15 メドジェニクス・メディカル・イスラエル・リミテッド Long-lasting pharmaceutical formulation
WO2012009377A2 (en) 2010-07-12 2012-01-19 University Of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
AU2011285639B2 (en) 2010-08-04 2014-12-18 Georgia Tech Research Corporation Devices, systems, and methods for excavating cancer cells
WO2012041320A1 (en) 2010-09-27 2012-04-05 Nsgene A/S Implantable cell device with supportive and radial diffusive scaffolding
WO2012041328A1 (en) 2010-10-01 2012-04-05 Nsgene A/S Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
WO2012075184A2 (en) 2010-12-02 2012-06-07 Neurotech Usa, Inc. Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
WO2012149468A2 (en) 2011-04-29 2012-11-01 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
KR102000141B1 (en) 2011-10-27 2019-07-15 웰스테이트 옵탈믹스 코퍼레이션 Vectors encoding rod-derived cone viability factor
US10232086B2 (en) 2011-11-16 2019-03-19 Empire Technology Development Llc Three-dimensional porous biodegradable cell scaffold
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
EP2817014A2 (en) 2012-02-21 2014-12-31 Baxter International Inc Pharmaceutical composition comprising cd34+ cells
US9101707B2 (en) 2012-04-27 2015-08-11 Gregory Zeltser Implantable bioartificial perfusion system
US20150150796A1 (en) 2012-05-30 2015-06-04 Neurotech Usa, Inc. Cryopreserved Implantable Cell Culture Devices and Uses Thereof
US20140017263A1 (en) 2012-06-28 2014-01-16 Clemson University Delivery Agents for Targeted Treatment of Elastin Degradation
WO2014011775A1 (en) 2012-07-10 2014-01-16 The Trustees Of The University Of Pennsylvania Biomaterials for enhanced implant-host integration
DE102013004595A1 (en) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV vaccines
CN105452447A (en) 2013-06-19 2016-03-30 脊核细胞有限责任公司 Adipose cells for chondrocyte applications
US9795573B2 (en) 2013-09-24 2017-10-24 Clemson University Multi-step connective tissue stabilization method and stabilized tissue formed thereby
US10159517B2 (en) 2014-07-07 2018-12-25 Stryker European Holdings I, Llc Bone plate with attachable wedge
US9764122B2 (en) 2014-07-25 2017-09-19 Warsaw Orthopedic, Inc. Drug delivery device and methods having an occluding member
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
EP3226835A4 (en) 2014-12-02 2018-09-26 Silk Therapeutics, Inc. Silk performance apparel and products and methods of preparing the same
ES2833457T3 (en) 2015-05-27 2021-06-15 Neurotech Usa Inc Use of encapsulated cell therapy for the treatment of glaucoma
EP3322434A4 (en) 2015-07-14 2019-01-09 Silk Therapeutics Inc. Silk performance apparel and products and methods of preparing the same
US11338065B2 (en) 2015-10-08 2022-05-24 Massachusetts Institute Of Technology In situ expansion of engineered devices for regeneration
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
US10549081B2 (en) 2016-06-23 2020-02-04 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
SG11201811763SA (en) 2016-07-18 2019-02-27 Eth Zuerich B-cell-mimetic cells
EP3272877A1 (en) 2016-07-18 2018-01-24 ETH Zurich B-cell-mimetic cells
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
CA3042495A1 (en) * 2016-11-10 2018-05-17 Viacyte, Inc. Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
JP6470327B2 (en) * 2017-02-07 2019-02-13 株式会社東芝 Fiber orientation material and method for producing the same
US20180222145A1 (en) * 2017-02-07 2018-08-09 Kabushiki Kaisha Toshiba Fiber-oriented material and method for manufacturing the same
CN111712514A (en) 2017-09-27 2020-09-25 自然进化公司 Silk coated fabrics and products and methods of making same
US10493233B1 (en) 2018-06-05 2019-12-03 Duke University Bi-directional access to tumors
JP6929424B2 (en) * 2019-01-17 2021-09-01 株式会社東芝 Manufacturing method of fiber alignment material

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5136810B2 (en) 1972-08-04 1976-10-12
US4686098A (en) 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
JPS6115687A (en) * 1984-06-29 1986-01-23 Japan Atom Energy Res Inst Immobilized multiplied microorganism and its preparation
JPS6394977A (en) * 1986-10-13 1988-04-26 Agency Of Ind Science & Technol Active filler and production thereof
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5786216A (en) * 1987-11-17 1998-07-28 Cytotherapeutics, Inc. Inner-supported, biocompatible cell capsules
DE3829752A1 (en) 1988-09-01 1990-03-22 Akzo Gmbh INTEGRAL ASYMMETRICAL POLYAETHERSULPHONE MEMBRANE, METHOD FOR THE PRODUCTION AND USE FOR ULTRAFILTRATION AND MICROFILTRATION
DE3829766A1 (en) 1988-09-01 1990-03-22 Akzo Gmbh METHOD FOR PRODUCING MEMBRANES
EP0585368B1 (en) 1991-04-25 1997-08-06 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5512600A (en) 1993-01-15 1996-04-30 Massachusetts Institute Of Technology Preparation of bonded fiber structures for cell implantation
DE938893T1 (en) * 1993-08-10 2000-03-09 Gore & Ass Cell encapsulation device
CA2169292C (en) 1993-08-12 2010-11-23 E. Edward Baetge Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5550050A (en) 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US5776747A (en) 1994-07-20 1998-07-07 Cytotherapeutics, Inc. Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
US5837234A (en) 1995-06-07 1998-11-17 Cytotherapeutics, Inc. Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
WO1997010807A1 (en) 1995-09-22 1997-03-27 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
US6054142A (en) 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US6303136B1 (en) * 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane

Also Published As

Publication number Publication date
EP1083945B1 (en) 2002-06-26
US6627422B1 (en) 2003-09-30
WO1999052573A1 (en) 1999-10-21
AU748691B2 (en) 2002-06-13
ATE219691T1 (en) 2002-07-15
AU3640599A (en) 1999-11-01
CA2328296C (en) 2008-07-08
DE69901957T2 (en) 2002-11-28
US6303136B1 (en) 2001-10-16
ES2178427T3 (en) 2002-12-16
DE69901957D1 (en) 2002-08-01
EP1083945A1 (en) 2001-03-21
DK1083945T3 (en) 2002-10-21

Similar Documents

Publication Publication Date Title
CA2328296A1 (en) Encapsulation devices with strand, yarn or mesh core
EP1427043A4 (en) Membrane, electrode assembly, its manufacturing method, and solid polyer fuel cell using the same
MXPA03007829A (en) Novel fuel cell cathodes and their fuel cells.
CA2377889A1 (en) Arranging control signallings in telecommunication system
DE69710218D1 (en) ELECTRODE PLATE STRUCTURES, ELECTROCHEMICAL HIGH PRESSURE CELLS AND MANUFACTURING METHOD THEREFOR
AU1523300A (en) Alkaline cell with improved cathode
AU5850200A (en) Positive plate active material, method for producing the same, and secondary cell
IL141730A0 (en) Membrane-separated, bipolar multicell electrochemical reactor
TW335563B (en) Porous metal, method of manufacturing it and battery pole plate using it
MXPA01009975A (en) Method for producing cathode active material and method for producing non-aqueous electrolyte cell.
MXPA01011968A (en) Materials and processes for providing fuel cells and active membranes.
GB2330836B (en) Solid polyelectrolyte membrane for fuel cells,and method for producing it
DE69529206D1 (en) Nickel electrode active material; Nickel electrode and alkaline nickel storage cell using such active material, and such material, electrode and cell manufacturing method
AU2711000A (en) Purged anode, low effluent fuel cell
EP0741429A3 (en) Metal-air cathode can and electrochemical cell made therewith
CA2235193A1 (en) Composite membranes
KR970707599A (en) Organic fuel cell, method of operating same, and method of manufacturing electrode for same (Organic fuel cell, and methods of operation the electrode and manufacture of electrode therefor)
EP1024502A4 (en) Composition for electrolyte, electrolyte and process for producing the same, and cell containing the same
EP1294032A3 (en) Assembled battery
AU2001296346A1 (en) Electrode catalyst composition, electrode and membrane electrode assembly for electrochemical cells
AU1869500A (en) An electro kinetic geosynthetic structure
AU1922500A (en) High rate electrochemical cell and assembly method
EP0681339A3 (en) Electrochemical cell.
FR2659496B1 (en) ELECTROCHEMICAL ACCUMULATOR ELEMENT, CATHODE ASSEMBLY FOR THE SAME AND MANUFACTURING METHOD THEREOF.
BR0210803B1 (en) ionomer, method of preparation and polymer electrolytic membrane comprising the same, membrane electrode assembly and fuel cell comprising such an assembly.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190415